Pathways controlling neurotoxicity and proteostasis in mitochondrial complex I deficiency
Human Molecular Genetics · 2024
DOI: 10.1093/hmg/ddae018 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Molecular Genetics, 2024. Verfasst von Vanitha Nithianandam und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, 77 Avenue Louis Pasteur, Boston, MA 02115, United States. Hauptthemen laut MEDLINE: Proteostasis, Electron Transport Complex I, Mitochondria, Drosophila Proteins. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, NINDS NIH HHS, ODCDC CDC HHS.
Abstract (Originalsprache)
Neuromuscular disorders caused by dysfunction of the mitochondrial respiratory chain are common, severe and untreatable. We recovered a number of mitochondrial genes, including electron transport chain components, in a large forward genetic screen for mutations causing age-related neurodegeneration in the context of proteostasis dysfunction. We created a model of complex I deficiency in the Drosophila retina to probe the role of protein degradation abnormalities in mitochondrial encephalomyopathies. Using our genetic model, we found that complex I deficiency regulates both the ubiquitin/proteasome and autophagy/lysosome arms of the proteostasis machinery. We further performed an in vivo kinome screen to uncover new and potentially druggable mechanisms contributing to complex I related neurodegeneration and proteostasis failure. Reduction of RIOK kinases and the innate immune signaling kinase pelle prevented neurodegeneration in complex I deficiency animals. Genetically targeting oxidative stress, but not RIOK1 or pelle knockdown, normalized proteostasis markers. Our findings outline distinct pathways controlling neurodegeneration and protein degradation in complex I deficiency and introduce an experimentally facile model in which to study these debilitating and currently treatment-refractory disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, 77 Avenue Louis Pasteur, Boston, MA 02115, United States.
- Aligning Science Across Parkinson's (ASAP) Collaborative Research Network, 5425 Wisconsin Avenue, Chevy Chase, MD 20815, United States.
ORCID-Profile: Mel B Feany
Förderung
- NIH HHS
- NINDS NIH HHS
- ODCDC CDC HHS
- Bloomington Drosophila Stock Center
- Harvard Medical School
- Developmental Studies Hybridoma Bank
- University of Iowa, Department of Biology
- Department of Defense
Zitieren
APA
Nithianandam, V., Sarkar, S., & Feany, M. B. (2024). Pathways controlling neurotoxicity and proteostasis in mitochondrial complex I deficiency. Human Molecular Genetics. https://doi.org/10.1093/hmg/ddae018
Vancouver
Nithianandam V, Sarkar S, Feany MB. Pathways controlling neurotoxicity and proteostasis in mitochondrial complex I deficiency. Human Molecular Genetics. 2024. doi:10.1093/hmg/ddae018
BibTeX
@article{Nithianandam2024,
author = {Nithianandam, Vanitha and Sarkar, Souvarish and Feany, Mel B},
title = {Pathways controlling neurotoxicity and proteostasis in mitochondrial complex I deficiency},
journal = {Human Molecular Genetics},
year = {2024},
doi = {10.1093/hmg/ddae018}
}
EUVIMED